Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.

Several infiltrating cells in the tumor microenvironment could influence the cancer progression via secreting various cytokines. Here, we found the CCL5 secreted from BM-MSCs suppressed androgen receptor (AR) signals via enhancing the expression of hypoxia inducible factor 2α (HIF2α) in prostate cancer (PCa) cells.

Mechanism dissection revealed that the increased HIF2α might alter the AR-HSP90 interaction to suppress the AR transactivation, and inhibition of HIF2α reversed the BM-MSCs-increased PCa stem cell population and PCa cells invasion. Importantly, CCL5 could suppress the prolyl hydroxylases (PHDs) expression, which might then lead to suppress VHL-mediated HIF2α ubiquitination. Together, these results demonstrated that the CCL5 signals from infiltrating BM-MSC cells to HIF2α signals within PCa cells might play a key role to increase PCa stem cell population and PCa metastasis via altering the AR signals. Targeting this newly identified CCL5/HIF2α/AR axis signal axis may allow us to develop a novel way to suppress PCa metastasis.

Oncotarget. 2015 Jul 27 [Epub ahead of print]

Jie Luo, Soo Ok Lee, Yun Cui, Rachel Yang, Lei Li, Chawnshang Chang

Departments of Pathology, Urology, Radiation Oncology, Biology, University of Rochester, Rochester, NY 14642, USA. , Departments of Pathology, Urology, Radiation Oncology, Biology, University of Rochester, Rochester, NY 14642, USA. , Departments of Pathology, Urology, Radiation Oncology, Biology, University of Rochester, Rochester, NY 14642, USA. , Departments of Pathology, Urology, Radiation Oncology, Biology, University of Rochester, Rochester, NY 14642, USA. , Departments of Pathology, Urology, Radiation Oncology, Biology, University of Rochester, Rochester, NY 14642, USA. , Departments of Pathology, Urology, Radiation Oncology, Biology, University of Rochester, Rochester, NY 14642, USA.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe